These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9269612)

  • 1. Long-term toxicity in adjuvant treatment with tamoxifen.
    Cobelli S; Dambrosio M; Farina G; Rovej R; Tomirotti M; Scanni A
    J Chemother; 1997 Aug; 9(4):300-3. PubMed ID: 9269612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen therapy--long-term results and complications.
    Moore MP; Kinne DW
    Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
    [No Abstract]   [Full Text] [Related]  

  • 3. The duration of adjuvant tamoxifen therapy.
    Bilimoria MM; Jordan VC
    Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tamoxifen and breast cancer: is everything known already?].
    Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
    Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
    [No Abstract]   [Full Text] [Related]  

  • 6. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
    Rutqvist LE
    J Natl Cancer Inst; 1996 Oct; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030
    [No Abstract]   [Full Text] [Related]  

  • 8. One step forward or one step back with tamoxifen?
    Gelmon K
    Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
    [No Abstract]   [Full Text] [Related]  

  • 9. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
    Gradishar WJ
    Oncology; 2005; 69(1):1-9. PubMed ID: 16088229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke risk and tamoxifen therapy for breast cancer.
    Geiger AM; Fischberg GM; Chen W; Bernstein L
    J Natl Cancer Inst; 2004 Oct; 96(20):1528-36. PubMed ID: 15494603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should tamoxifen users be screened for endometrial lesions?
    Neven P; Vergote I
    Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
    [No Abstract]   [Full Text] [Related]  

  • 13. The breast cancer prevention trial: should women at risk take tamoxifen?
    McKeon VA
    J Obstet Gynecol Neonatal Nurs; 1999; 28(6 Suppl 1):34-8. PubMed ID: 10608495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tamoxifen and endometrial cancer. A case report].
    Orbo A; Lindal S; Mortensen E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(16):1877-8. PubMed ID: 8711699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
    Rouanet P; Linares-Cruz G; Dravet F; Poujol S; Gourgou S; Simony-Lafontaine J; Grenier J; Kramar A; Girault J; Le Nestour E; Maudelonde T
    J Clin Oncol; 2005 May; 23(13):2980-7. PubMed ID: 15860853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-benefit profiles of women using tamoxifen for chemoprevention.
    Nichols HB; DeRoo LA; Scharf DR; Sandler DP
    J Natl Cancer Inst; 2015 Jan; 107(1):354. PubMed ID: 25475563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen in cancer therapy: minireview.
    Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
    Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    Mäenpää J; Ellmén J; Pasanen T; Kaukonen M
    J Natl Cancer Inst; 1999 Jun; 91(11):972-3. PubMed ID: 10359551
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of endometrial cancer in breast cancer patients under long-term adjuvant treatment with tamoxifen.
    Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Pacini P; Muraca MG; Zappa M
    Tumori; 1998; 84(1):21-3. PubMed ID: 9619708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.